Jeffrey Moe, professor in the Health Sector Management program at Duke’s Fuqua School of Business, takes a look at neglected diseases through the lens of business in the eighth article the Duke Chronicle’s series on global health.
Researchers at Duke and other centers world-wide have found that eltrombopag (marketed as Promacta in the US and Revolade in Europe) boosted platelet counts in a majority of patients with low platelet counts and cirrhosis of the liver due to hepatitis C virus infection. Higher platelet counts enabled most patients to continue or start conventional antiviral treatment. Unlike other drugs that restore normal platelet functions but are given through infusions or injections, eltrombopag is a pill taken just once a day.
Led by Michael Merson, MD, the institute is built on collaboration among researchers from schools and departments throughout Duke University in an effort to combat global health problems like HIV/AIDS and cancer and to address the economic, social, environmental, and political issues associated with global healthcare.
More than $45,000 in funding recently was awarded to Duke faculty and staff who submitted proposals earlier in the semester to the Duke Center for Civic Engagement (DCCE) to explore sites around the globe as potential DukeEngage programs in the coming years.
Michael Merson, M.D., director of the Duke Global Health Institute, has agreed to serve as chairman of the MIDAS Steering Committee starting with the May 2008 meeting.
In the middle of a Venn diagram where human health concerns like cancer, diabetes and asthma meet real-world environmental conditions like water pollution, lead paint and social stress, a growing collaboration of Duke researchers have begun digging.
Duane Gubler, an internationally recognized expert on dengue fever, has taken on the post of Director – Emerging Infectious Diseases research program at the Duke-NUS Graduate Medical School in Singapore. His appointment was effective Nov. 1, 2007.
Phil Costanzo writes Duke ChroniclePart 7 in a series on global health in the Duke Chronicle. Obesity is an important focus of global health efforts today because it is a premorbid state that can be preventable with increases in our scientific understanding of the sources of its “spread.”
The stories on the evening news about the tragic health problems that plague people in developing nations can seem very far removed from North Carolina. But when it comes to global health, the world is a small place indeed.
Robert Malkin, a professor of the practice in biomedical engineering at Duke University’s Pratt School of Engineering and a founder of Engineering World Health (EWH), has accepted a new role as a representative to the Executive Board of the World Health Organization (WHO) beginning in January 2008, when he will attend his first board meeting and The World Health Assembly in Geneva.